DB
MD icon

Dmitry Balyasny’s Pediatrix Medical MD Stock Holding History

Dmitry Balyasny’s Portfolio MD Stock Details MD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-100,000
Closed -$2.1M – 3098
2022
Q2 		$2.1M Buy
+100,000
New +$2.04M 0.01% 1371
2022
Q1 		– Sell
-150,000
Closed -$4.08M – 2693
2021
Q4 		$4.08M Buy
+150,000
New +$4.02M 0.01% 907

Other funds holding MD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Dmitry Balyasny's MD Position: Q2 2026 in Review

Dmitry Balyasny sold out of Pediatrix Medical (MD) in Q2 2026, closing a stake of 10,860 shares — an estimated $232K sold.

Dmitry Balyasny first reported a position in MD in Q3 2015 and held it in 14 quarters. The position peaked at $64M in Q2 2017. 302 funds tracked by Wall St. Rank hold MD as of Q2 2026.

  • Dmitry Balyasny reported no remaining Pediatrix Medical position as of Q2 2026 after selling out during the quarter.
  • Dmitry Balyasny sold 10,860 Pediatrix Medical shares in Q2 2026, an estimated $232K.
  • Dmitry Balyasny first reported a position in Pediatrix Medical in Q3 2015 and held it in 14 quarters.
  • Dmitry Balyasny's Pediatrix Medical position peaked at $64M in Q2 2017.
  • 302 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.